MRK vs PFE
By Alex · Tickerpine
Merck & Co., Inc. vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | PFE |
|---|---|---|
| Price | $145.27 | $30.03 |
| Market cap | $358.41B | $171.16B |
| P/E ratio | 117.2 | 39.5 |
| ROE | 6.96% | 5.01% |
| Profit margin | 4.77% | 6.80% |
| Revenue growth | 5.10% | 2.60% |
| Dividend yield | 2.34% | 5.73% |
| Beta | 0.22 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs PFE in plain English
- MRK is the bigger company — about 2.1× the market cap of PFE.
- PFE is cheaper on earnings (P/E 39.5 vs 117.2).
- MRK earns a higher return on equity (7% vs 5%).
- MRK is growing revenue faster (5% vs 3%).
- PFE has the higher dividend yield (5.73% vs 2.34%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.